KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Opko Health (OPK) EPS (Weighted Average and Diluted) (2016 - 2025)

Opko Health (OPK) has disclosed EPS (Weighted Average and Diluted) for 15 consecutive years, with -$0.04 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EPS (Weighted Average and Diluted) fell 500.0% year-over-year to -$0.04, compared with a TTM value of -$0.3 through Dec 2025, down 233.33%, and an annual FY2025 reading of -$0.3, down 3100.0% over the prior year.
  • EPS (Weighted Average and Diluted) was -$0.04 for Q4 2025 at Opko Health, down from $0.03 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $0.05 in Q1 2021 and bottomed at -$0.19 in Q2 2025.
  • Average EPS (Weighted Average and Diluted) over 5 years is -$0.06, with a median of -$0.06 recorded in 2022.
  • The sharpest move saw EPS (Weighted Average and Diluted) surged 155.56% in 2021, then tumbled 1800.0% in 2025.
  • Year by year, EPS (Weighted Average and Diluted) stood at -$0.12 in 2021, then grew by 8.33% to -$0.11 in 2022, then rose by 18.18% to -$0.09 in 2023, then soared by 111.11% to $0.01 in 2024, then tumbled by 500.0% to -$0.04 in 2025.
  • Business Quant data shows EPS (Weighted Average and Diluted) for OPK at -$0.04 in Q4 2025, $0.03 in Q3 2025, and -$0.19 in Q2 2025.